Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-18-000439

Chief Medical Officer and SVP acquired 13,892 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stromatt Scott C Chief Medical Officer and SVP 2018-03-09 Option exercise +13,892 204,737 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stromatt Scott C Chief Medical Officer and SVP 2018-03-09 Grant or award · Employee Stock Options (Right to Buy) +67,400 67,400 D: show line 2 in the form
Stromatt Scott C Chief Medical Officer and SVP 2018-03-09 Option exercise · Restricted Stock Unit −13,892 16,269 D: show line 3 in the form
Loading xslF345X03/stromatt_4.xml…